Advertisement
Research Article| Volume 218, ISSUE 1, P174-180, September 2011

Effect of a traditional Mediterranean diet on apolipoproteins B, A-I, and their ratio: A randomized, controlled trial

  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Rosa Solá
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Human Nutrition Department, School of Medicine, University Rovira i Virgili, Reus, Spain

    CIBER de Diabetes (CIBERDEM), Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Montserrat Fitó
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain

    Cardiovascular Risk and Nutrition and Human Neurosciences Research Groups, IMIM-Institut de Recerca del Hospital del Mar, Barcelona, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Ramón Estruch
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain

    Departments of Internal Medicine, Biochemistry, and Endocrinology, Hospital Clinic, IDIBAPS, Barcelona, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Jordi Salas-Salvadó
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Human Nutrition Department, School of Medicine, University Rovira i Virgili, Reus, Spain

    CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Dolores Corella
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain

    Department of Preventive Medicine and Public Health, University of Valencia, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Rafael de La Torre
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain

    Cardiovascular Risk and Nutrition and Human Neurosciences Research Groups, IMIM-Institut de Recerca del Hospital del Mar, Barcelona, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Miguel Angel Muñoz
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Primary Health Care Division and Research, IDIAP-Jordi Gol, Barcelona, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    María del Carmen López-Sabater
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Department of Nutrition and Bromatology, University of Barcelona, CIBER de Epidemiología y Sallud Pública (CIBERESP), Barcelona, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Miguel-Angel Martínez-González
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Department of Preventive Medicine and Public Health, University of Navarra, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Fernando Arós
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Department of Cardiology, Hospital Txangorritxu, Vitoria, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Valentina Ruiz-Gutierrez
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Instituto de la Grasa, CSIC, Sevilla, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Miquel Fiol
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain

    University Institute for Health Sciences Investigation, Palma de Mallorca, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Elena Casals
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Departments of Internal Medicine, Biochemistry, and Endocrinology, Hospital Clinic, IDIBAPS, Barcelona, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Julia Wärnberg
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Department of Preventive Medicine and Public Health, University of Navarra, Spain

    Department of Preventive Medicine, University of Málaga, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Pilar Buil-Cosiales
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Departments of Internal Medicine, Biochemistry, and Endocrinology, Hospital Clinic, IDIBAPS, Barcelona, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Emilio Ros
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Valentini Konstantinidou
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Hellenic Health Foundation, Athenes, Greece
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    José Lapetra
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain

    Department of Family Medicine, Primary Care Division of Sevilla, San Pablo Health Center, Sevilla, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Lluis Serra-Majem
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    Department of Clinical Sciences, University of Las Palmas de Gran Canaria, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    María-Isabel Covas
    Correspondence
    Corresponding author at: Cardiovascular Risk and Nutrition Research Group, IMIM-Institut de Recerca del Hospital del Mar, Barcelona Biomedical Research Parc (PRBB), Carrer Dr. Aiguader 88, 08003 Barcelona, Spain. Tel.: +34 933160720/34; fax: +34 933160796.
    Footnotes
    1 On behalf of the PREDIMED Study Investigators.
    Affiliations
    CIBER de Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Spain

    Cardiovascular Risk and Nutrition and Human Neurosciences Research Groups, IMIM-Institut de Recerca del Hospital del Mar, Barcelona, Spain
    Search for articles by this author
  • Author Footnotes
    1 On behalf of the PREDIMED Study Investigators.

      Abstract

      Objectives

      Apolipoprotein (Apo)B, ApoA-I, and their ratio could predict coronary heart disease (CHD) risk more accurately than conventional lipid measurements. Our aim was to assess the effect of a traditional Mediterranean diet (TMD) on apolipoproteins.

      Methods

      High-cardiovascular risk subjects (n = 551, 308 women and 243 men), aged 55–80 years, were recruited into a large, multicenter, randomized, controlled, parallel-group, clinical trial (The PREDIMED Study) aimed at testing the efficacy of TMD on primary cardiovascular disease prevention. Participants assigned to a low-fat diet (control) (n = 177), or TMDs (TMD + virgin olive oil (VOO), n = 181 or TMD + nuts, n = 193) received nutritional education and either free VOO (ad libitum) or nuts (dose: 30 g/day). A 3-month evaluation was performed.

      Results

      Both TMDs promoted beneficial changes on classical cardiovascular risk factors. ApoA-I increased, and ApoB and ApoB/ApoA-I ratio decreased after TMD + VOO, the changes promoting a lower cardiometabolic risk. Changes in TMD + VOO versus low-fat diet were −2.9 mg/dL (95% CI, −5.6 to −0.08), 3.3 mg/dL (95% CI, 0.84 to 5.8), and −0.03 mg/dL (−0.05 to −0.01) for ApoB, ApoA-I, and ApoB/ApoA-I ratio, respectively.

      Conclusions

      Individuals at high-cardiovascular risk who improved their diet toward a TMD pattern rich in virgin olive oil, reduced their Apo B and ApoB/ApoA-I ratio and improved ApoA-I concentrations.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Trichopoulou A.
        • Costacou T.
        • Bamia C.
        • Trichopoulos D.
        Adherence to a Mediterranean diet and survival in a Greek population.
        N Engl J Med. 2003; 348: 2599-2608
        • Estruch R.
        • Martínez-González M.A.
        • Corella D.
        • et al.
        Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial.
        Ann Intern Med. 2006; 145: 1-11
        • McQueen M.
        • Hawken S.
        • Wang X.
        • et al.
        Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study: a case–control study).
        Lancet. 2008; 372: 224-233
        • Parish S.
        • Peto R.
        • Palmer A.
        • et al.
        The joint effects of apolipoprotein B, apolipoprotein A-I, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.
        Eur Heart J. 2009; 30: 2137-2146
        • Walldius G.
        • Aastveit A.H.
        • Jungner I.
        Stroke mortality and the apoB/apo-A-I ratio: results of the AMORIS prospective study.
        J Int Med. 2006; 259: 259-266
        • Carter S.J.
        • Roberts M.B.
        • Salter J.
        • Eaton C.B.
        Relationship between Mediterranean Diet Score and atherothromboyic risk: findings from the Third National Health and Nutrition Examination Survey (NHANES III), 1988–1994.
        Atherosclerosis. 2010; 2: 630-636
        • Violante B.
        • Gerbaudo L.
        • Borretta G.
        • Tassone F.
        Effects of extra virgin olive oil supplementation at two different low doses on lipid profile in mild hypercholesterolemic subjects: a randomised clinical trial.
        J Endocrinol Invest. 2009; 32: 794-796
        • Li T.Y.
        • Brennan A.M.
        • Wedick N.M.
        • Mantzoros C.
        • Rifai N.
        • Hu F.B.
        Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes.
        J Nutr. 2009; 139: 1333-1338
        • Martínez-González M.A.
        • Fernández-Jarné E.
        • Serrano-Martínez M.
        • Wright M.
        • Gómez-Gracia E.
        Development of a short dietary questionnaire for the quantitative estimation of adherence to a cardioprotective Mediterranean diet.
        Eur J Clin Nutr. 2004; 58: 1550-1552
        • Fernández-Ballart J.D.
        • Piñol J.L.
        • Zazpe I.
        • et al.
        Relative validity of a semi-quantitative food-frequency questionnaire in an elderly Mediterranean population of Spain.
        Br J Nutr. 2010; 103: 1808-1816
        • Elosua R.
        • García M.
        • Aguilar A.
        • et al.
        Validation of the Minnesota Leisure time physical activity questionnaire in Spanish women.
        Med Sci Sports Med. 2000; 32: 1431-1437
        • Martínez-González M.A.
        • Corella D.
        • Salas-Salvadó J.
        • et al.
        Cohort profile: design and methods of the PREDIMED study.
        Int J Epidemiol. 2010; ([December 20; Epub ahead of print])
        • Marrugat J.
        • Subirana I.
        • Comín E.
        • et al.
        Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study.
        J Epidemiol Community Health. 2007; 61 ([Erratum in: J Epidemiol Community Health 2007;61:655]): 40-47
        • Walldius G.
        • Jungner I.
        The apoB/apoA-I ratio: a strong, new risk factor for cardiovascular disease and a target for lipid-lowering therapy—a review of the evidence.
        J Int Med. 2006; 259: 493-519
        • Brunzell J.D.
        • Davidson M.
        • Furberg C.D.
        • et al.
        Lipoprotein management in patients with cardiometabolic risk: Consensus Conference Report from the American Diabetes Association and the American College of Cardiology Foundation.
        J Am Coll Cardiol. 2008; 51: 1512-1524
        • Fuentes F.
        • López-Miranda J.
        • Sánchez E.
        • et al.
        Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men.
        Ann Int Med. 2001; 134: 1115-1119
        • Harper C.H.
        • Jacobson T.A.
        Using apolipoprotein B to manage dyslipidemic patients: time for a change?.
        Mayo Clin Proc. 2010; 85: 440-445
        • Barter
        • Ballatyne C.M.
        • Carmena R.
        • et al.
        Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel.
        J Int Med. 2006; 259: 437-446
        • Lind L.
        Apolipoprotein B/A-I and risk of cardiovascular disease.
        Lancet. 2008; 372: 185-186
        • Moller C.S.
        • Zethelius B.
        • Sundstrom J.
        • et al.
        Impact of follow-up time and re-measurement of the electrocardiogram and conventional cardiovascular risk factors on their predictive value for myocardial infarction.
        J Intern Med. 2006; 260: 22-30
        • López-Soldado I.
        • Avella M.
        • Botham K.M.
        Differential influence of different dietary fatty acids on very low-density lipoprotein secretion when delivered to hepatocytes in chylomicron remnants.
        Metabolism. 2009; 58: 186-195
        • Perona J.S.
        • Avella M.
        • Botham K.M.
        • Ruiz-Gutierrez V.
        Differential modulation of hepatic very low-density lipoprotein secretion by triacylglycerol-rich lipoproteins derived from different oleic-acid rich dietary oils.
        Br J Nutr. 2008; 99: 29-36
        • Calleja L.
        • Trallero M.C.
        • Carrizosa C.
        • Méndez M.T.
        • Palacios-Alaiz E.
        • Osada J.
        Effects of dietary fat amount and saturation on the regulation of hepatic mRNA and plasma apolipoprotein A-I in rats.
        Atherosclerosis. 2000; 152: 69-78
        • Yasuda A.
        • Natsume M.
        • Osakabe N.
        • Kawahata K.
        • Koga J.
        Cacao polyphenols influence the regulation of apolipoprotein in HepG2 and Caco2 cells.
        J Agric Food Chem. 2011; 59: 1470-1476
        • Bladé C.
        • Arola L.
        • Salvadó M.-J.
        Hypolipidemic effects of proanthocyanidins and their underlying biochemical and molecular mechanisms.
        Mol Nutr Res. 2010; 54: 37-59
        • Borradaile N.M.
        • de Dreu L.E.
        • Barrett P.H.
        • Behrsin C.D.
        • Huff M.W.
        Hepatocyte apoB-containing lipoprotein secretion is decreased by the grapefruit flavonoid, naringenin, via inhibition of MTP-mediated microsomal triglyceride accumulation.
        Biochemistry. 2003; 42: 1283-1291
        • Welty F.K.
        • Lee K.S.
        • Lew N.S.
        • Zhou J.-R.
        Effect of soy nuts on blood pressure and lipid levels in hypertensive, prehypertensive, and normotensive postmenopausal women.
        Arch Intern Med. 2007; 167: 1060-1067
        • Pipe E.A.
        • Gobert C.P.
        • Capes S.E.
        • Darlington G.A.
        • Lampe J.W.
        • Duncan A.M.
        Soy protein reduces serum LDL cholesterol and the LDL cholesterol: HDL cholesterol and apolipoprotein B: apolipoprotein A-I ratios in adults with type 2 diabetes.
        J Nutr. 2009; 139: 1700-1706
        • Echarri C.P.
        • Dávalos A.
        • Cerrato F.
        • et al.
        Concentrated grape juice exerts antioxidant, hypolipidemic and anti-inflammatory effects in both hemodialysis patients and healthy subjects.
        Am J Clin Nutr. 2006; 84: 252-256
        • Miquel J.
        • Bernd A.
        • Sempere J.M.
        • Díaz-Alperi J.
        • Ramíres A.
        The curcuma antioxidants: pharmacological effects and prospects for future clinical use: a review.
        Arch Gerontol Geriatr. 2002; 34: 37-46